2994 Federal Register / Vol. 83, No. 14 / Monday, January 22, 2018 / Notices 

Commission, Office of the Secretary, 

Constitution Center, 400 7th Street SW, 

5th Floor, Suite 5610, Washington, DC 

20024. If possible, submit your paper 

comment to the Commission by courier 

or overnight service. 

Because your comment will be placed 

on the publicly accessible FTC website 

at https://www.ftc.gov, you are solely 

responsible for making sure that your 

comment does not include any sensitive 

or confidential information. In 

particular, your comment should not 

include any sensitive personal 

information, such as your or anyone 

else’s Social Security number; date of 

birth; driver’s license number or other 

state identification number, or foreign 

country equivalent; passport number; 

financial account number; or credit or 

debit card number. You are also solely 

responsible for making sure that your 

comment does not include any sensitive 

health information, such as medical 

records or other individually 

identifiable health information. In 

addition, your comment should not 

include any ‘‘trade secret or any 

commercial or financial information 

which . . . is privileged or 

confidential’’—as provided by Section 

6(f) of the FTC Act, 15 U.S.C. 46(f), and 

FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)— 

including in particular competitively 

sensitive information such as costs, 

sales statistics, inventories, formulas, 

patterns, devices, manufacturing 

processes, or customer names. 

Comments containing material for 

which confidential treatment is 

requested must be filed in paper form, 

must be clearly labeled ‘‘Confidential,’’ 

and must comply with FTC Rule 4.9(c). 

In particular, the written request for 

confidential treatment that accompanies 

the comment must include the factual 

and legal basis for the request, and must 

identify the specific portions of the 

comment to be withheld from the public 

record. See FTC Rule 4.9(c). Your 

comment will be kept confidential only 

if the General Counsel grants your 

request in accordance with the law and 

the public interest. Once your comment 

has been posted on the public FTC 

website—as legally required by FTC 

Rule 4.9(b)—we cannot redact or 

remove your comment from the FTC 

website, unless you submit a 

confidentiality request that meets the 

requirements for such treatment under 

FTC Rule 4.9(c), and the General 

Counsel grants that request. 

Visit the Commission website at 

https://www.ftc.gov to read this Notice. 

The FTC Act and other laws that the 

Commission administers permit the 

collection of public comments to 

consider and use in this proceeding as 

appropriate. The Commission will 

consider all timely and responsive 

public comments that it receives on or 

before March 23, 2018. You can find 

more information, including routine 

uses permitted by the Privacy Act, in 

the Commission’s privacy policy, at 

https://www.ftc.gov/site-information/ 

privacy-policy. 

David C. Shonka, 

Acting General Counsel. 

[FR Doc. 2018–00980 Filed 1–19–18; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Health Statistics 

(NCHS), ICD–10 Coordination and 

Maintenance (C&M) Committee 

Meeting 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: The CDC, National Center for 

Health Statistics (NCHS), Classifications 

and Public Health Data Standards Staff, 

announces the following meeting of the 

ICD–10 Coordination and Maintenance 

(C&M) Committee meeting. This 

meeting is open to the public, limited 

only by the space available. The meeting 

room accommodates approximately 240 

people. The meeting will be broadcast 

live via Webcast at http://www.cms.gov/ 

live/. 

DATES: The meeting will be held on 

March 6, 2018, 9:00 a.m. to 5:00 p.m. 

EST and March 7, 2018x, 9:00 a.m. to 

5:00 p.m. EST. 

ADDRESSES: Centers for Medicare and 

Medicaid Services (CMS) Auditorium, 

7500 Security Boulevard, Baltimore, 

Maryland 21244. 

FOR FURTHER INFORMATION CONTACT: 

Traci Ramirez, Program Specialist, CDC, 

3311 Toledo Rd., Hyattsville, MD 20782; 

telephone (301) 458–4454; Email 

address TRamirez@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The ICD–10 Coordination 

and Maintenance (C&M) Committee is a 

public forum for the presentation of 

proposed modifications to the 

International Classification of Diseases, 

Tenth Revision, Clinical Modification 

and ICD–10 Procedure Coding System. 

Matters to be Considered: The agenda 

will include discussions on ICD–10–PCS 

Topics: 

Blalock-Taussig Shunt Occlusion 

Knee Replacement 

Irreversible Electroporation (IRE) 

Endovascular Cardiac Implant 

Combined Thoracic Arch Replacement 

and Thoracic Aorta Restriction 

Spinal Fusion with Radiolucent 

Hydroxyapatite 

Interbody Fusion Device 

Endovascular Intracranialy 

Thrombectomy 

Cell Suspension Autografting 

Trigard Cerebral Embolic Protection 

Endobronchial Coils 

Addenda and Key Updates 

ICD–10–CM Topics: 

Cyclic Vomiting 

Electronic Nicotine Delivery System 

(ENDS) 

Exertional Heat Stroke 

Intracranial Hypotension 

ICD–10–CM Addendum 

Agenda items are subject to change as 

priorities dictate. 

Security Considerations: Due to 

increased security requirements CMS 

has instituted stringent procedures for 

entrance into the building by nongovernment employees. Attendees will 

need to present valid government-issued 

picture identification, and sign-in at the 

security desk upon entering the 

building. 

Attendees who wish to attend the 

March 6–7, 2018, ICD–10–CM C&M 

meeting must submit their name and 

organization by March 1, 2018, for 

inclusion on the visitor list. This visitor 

list will be maintained at the front desk 

of the CMS building and used by the 

guards to admit visitors to the meeting. 

Participants who attended previous 

Coordination and Maintenance meetings 

will no longer be automatically added to 

the visitor list. You must request 

inclusion of your name prior to each 

meeting you wish attend. 

Please register to attend the meeting 

on-line at: http://www.cms.hhs.gov/ 

apps/events/. 

Please contact Mady Hue (410–786– 

4510) or Marilu.hue@cms.hhs.gov for 

questions about the registration process. 

Note: CMS and NCHS no longer provide 

paper copies of handouts for the meeting. 

Electronic copies of all meeting materials 

will be posted on the CMS and NCHS 

websites prior to the meeting at http://

www.cms.hhs.gov/ 

ICD9ProviderDiagnosticCodes/03_

meetings.asp#TopOfPage and https://

www.cdc.gov/nchs/icd/icd10cm_

maintenance.htm. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 


ethrower on DSK3G9T082PROD with NOTICES
Federal Register / Vol. 83, No. 14 / Monday, January 22, 2018 / Notices 2995 

Centers for Disease Control and 

Prevention, and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2018–00967 Filed 1–19–18; 8:45 am] 

BILLING CODE 4160–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket Number: CDC–2018–0002; NIOSH 

248–G] 

World Trade Center Health Program 

Scientific/Technical Advisory 

Committee (WTCHP STAC) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC National Institute for Occupational 

Safety and Health (NIOSH), announces 

the following meeting for the World 

Trade Center Health Program Scientific/ 

Technical Advisory Committee (WTCHP 

STAC). This meeting is open to the 

public, limited only by the number of 

telephone lines. The room will 

accommodate approximately 100 

persons. The public is also welcome to 

listen to the meeting by dial-in number 

1 (888) 982–4611, the passcode 

3778171, and will accommodate up to 

50 callers. To view the web conference, 

enter the following web address in your 

web browser: https://

odniosh.adobeconnect.com/ 

wtchpstac18-1/. 

DATES: The meeting will be held on 

March 1, 2018, 9:00 a.m. to 4:00 p.m., 

EST. Public comment time will be from 

9:15 a.m. to 9:30 a.m., EST. 

Please note that the public comment 

period ends at the time indicated above 

or following the last call for comments, 

whichever is earlier. Members of the 

public who want to comment must sign 

up by providing their name to Mia 

Wallace, Committee Management 

Specialist, by phone: (404) 498–2553, 

email: MWallace@cdc.gov, or the 

addresses provided below by February 

16, 2018. Each commenter will be 

provided up to five minutes for 

comment. A limited number of time 

slots are available and will be assigned 

on a first come—first served basis. 

Written comments will also be accepted 

from those unable to attend the public 

session. 

ADDRESSES: Jacob J. Javits Federal 

Building, 26 Federal Plaza, New York, 

New York 10278. 

FOR FURTHER INFORMATION CONTACT: Paul 

J. Middendorf, Ph.D., Designated 

Federal Officer, NIOSH, CDC, 2400 

Century Parkway NE, Mail Stop E–20, 

Atlanta, Georgia 30345, telephone 

1 (888) 982–4748; email: wtc-stac@

cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The Advisory Committee 

was established by Title I of the James 

Zadroga 9/11 Health and Compensation 

Act of 2010, Public Law 111–347 

(January 2, 2011), amended by Public 

Law 114–113 (Dec. 18, 2015), adding 

Title XXXIII to the Public Health 

Service Act (codified at 42 U.S.C. 

300mm to 300mm–61). 

Purpose: The purpose of the Advisory 

Committee is to review scientific and 

medical evidence and to make 

recommendations to the World Trade 

Center (WTC) Program Administrator 

regarding additional WTC Health 

Program eligibility criteria, potential 

additions to the list of covered WTCrelated health conditions, and research 

regarding certain health conditions 

related to the September 11, 2001 

terrorist attacks. 

Title XXXIII of the PHS Act 

established the WTC Health Program 

within the Department of Health and 

Human Services (HHS). The WTC 

Health Program provides medical 

monitoring and treatment benefits to 

eligible firefighters and related 

personnel, law enforcement officers, 

and rescue, recovery, and cleanup 

workers who responded to the 

September 11, 2001, terrorist attacks in 

New York City, at the Pentagon, and in 

Shanksville, Pennsylvania (responders), 

and to eligible persons who were 

present in the dust or dust cloud on 

September 11, 2001 or who worked, 

resided, or attended school, childcare, 

or adult daycare in the New York City 

disaster area (survivors). Certain specific 

activities of the WTC Program 

Administrator are reserved to the 

Secretary, HHS, to delegate at her 

discretion; other WTC Program 

Administrator duties not explicitly 

reserved to the Secretary, HHS, are 

assigned to the Director, NIOSH. The 

administration of the Advisory 

Committee is left to the Director of 

NIOSH in his role as WTC Program 

Administrator. CDC and NIOSH provide 

funding, staffing, and administrative 

support services for the Advisory 

Committee. The charter was reissued on 

May 12, 2017, and will expire on May 

12, 2019. 

Policy on Redaction of Committee 

Meeting Transcripts (Public Comment): 

Transcripts will be prepared and posted 

to http://www.regulations.gov within 60 

days after the meeting. If a person 

making a comment gives his or her 

name, no attempt will be made to redact 

that name. NIOSH will take reasonable 

steps to ensure that individuals making 

public comments are aware of the fact 

that their comments (including their 

name, if provided) will appear in a 

transcript of the meeting posted on a 

public website. Such reasonable steps 

include a statement read at the start of 

the meeting stating that transcripts will 

be posted and names of speakers will 

not be redacted. If individuals in 

making a statement reveal personal 

information (e.g., medical information) 

about themselves, that information will 

not usually be redacted. The CDC 

Freedom of Information Act coordinator 

will, however, review such revelations 

in accordance with the Freedom of 

Information Act and, if deemed 

appropriate, will redact such 

information. Disclosures of information 

concerning third party medical 

information will be redacted. 

Matters To Be Considered: The agenda 

will include discussions on 

recommendations regarding the 

identification of individuals to conduct 

independent peer reviews of the 

evidence that would be the basis for 

issuing final rules to add a health 

condition to the List of WTC-Related 

Health Conditions, and World Trade 

Center Health-Related Research. Agenda 

items are subject to change as priorities 

dictate. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2018–00968 Filed 1–19–18; 8:45 am] 

BILLING CODE 4163–19–P 


ethrower on DSK3G9T082PROD with NOTICES